Publications
Systematic Development of Small Molecules to Inhibit Specific Microscopic Steps of Amyloid-Beta42 Aggregation in Alzheimer's Disease
Biophysical Journal
(2018)
114
225a
(doi: 10.1016/j.bpj.2017.11.1253)
Modulating Amyloid-Beta Aggregation to Reduce the Toxicity of its Oligomeric Aggregates
Biophysical Journal
(2018)
114
430a
(doi: 10.1016/j.bpj.2017.11.2382)
Probing the Interaction of ABETA42 Amyloid Species with an Aggregation Suppressor Molecule by Infrared Nanospectroscopy
Biophysical Journal
(2018)
114
224a
(doi: 10.1016/j.bpj.2017.11.1246)
Monomeric and fibrillar α-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of Aβ42 aggregates
Proceedings of the National Academy of Sciences
(2017)
114
8005
(doi: 10.1073/pnas.1700239114)
Attenuating the Toxicity of Amyloid-Beta Aggregation with Specific Species
Biophysical Journal
(2017)
112
494A
(doi: 10.1016/j.bpj.2016.11.2673)
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease.
Proc Natl Acad Sci U S A
(2016)
114
E200
(doi: 10.1073/pnas.1615613114)
A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
ACS Combinatorial Science
(2016)
18
144
(doi: 10.1021/acscombsci.5b00129)
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease
Science Advances
(2016)
2
e1501244
(doi: 10.1126/sciadv.1501244)
- ‹ previous
- Page 2
